Quercetin, a plant-derived flavonoid with potent antioxidant and anti-inflammatory properties, is limited for topical use by its poor aqueous solubility, low bioavailability, and chemical instability. This research developed and validated a formulation-driven strategy to stabilize quercetin by encapsulating it in lipid nanoparticles (QLNs) and embedding these in a Carbopol hydrogel, providing comprehensive physicochemical and functional stability data. A fully validated HPLC-PDA assay was used to quantify quercetin in the nanoparticle–hydrogel matrix. In vitro bioactivity testing showed notable antioxidant activity (DPPH IC50 6.84 ± 0.12 µg/mL; ABTS IC50 4.04 ± 0.08 µg/mL; FRAP 301.46 ± 3.68 µg/mL) and an anti-inflammatory effect in LPS-stimulated RAW264.7 macrophages (1 µM quercetin reduced NO from 50.72 ± 2.00 µM to 41.57 ± 3.12 µM, p 90% quercetin and preserving antioxidant and anti-inflammatory activities (<10% reduction). These results establish a robust, application-ready approach for maintaining quercetin’s chemical integrity and bioactivity in topical formulations.
Tangjidapichai et al. (Wed,) studied this question.